The Federal Trade Commission’s (FTC) two sitting members plan to hold a closed-door meeting on June 29 as the agency intensifies its focus on Walgreens Boots Alliance’s bid for Rite Aid, the commission announced Monday.
The commission has until July 7 to either clear or challenge the companies’ deal, which was announced in October 2015. It is valued around US$7 billion, according to Bloomberg, down from around US$9.4 billion when the deal was announced.
The content of the meeting isn’t officially known; FTC spokeswoman Betsy Lordan said the agency doesn’t comment on the content of closed-door meetings. The FTC is required by law to announce meetings between a quorum of commissioners.
Although the subject matter of the meeting is private, there is speculation that the commissioners must decide how to resolve their review of Walgreens and Rite Aid. The transaction would combine the No. 2 and No. 3 pharmacy chains in the US. The companies have been struggling for over a year to resolve competition concerns at the FTC.
The July 7 deadline for a decision was triggered on May 8, when the companies “certified compliance” with FTC investigatory demands, which set off a 30-day clock for the commissioners to action or allow the deal to go through with no conditions. In this case, the parties agreed to a 60-day deadline.
If the FTC takes no action by that date, the deal would go through.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas